Notably, detection of autoantibodies against ENOA combined with expression of carcino-embryonic antigen (CEA) and CK19 fragment enhances the sensitivity for differential diagnosis of NSCLC [184]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.